Clinical Trials in Colorado

Showing 8421-8440 of 18,143 trials

Evaluation of Topical Application of BMX-010 in Subjects With Rosacea

NCT03756389

This is an exploratory Phase 2 trial of BMX-010 in patients with Rosacea which will be conducted in two parts. Up to 210 subjects with Rosacea will be enrolled.

Rosacea

BioMimetix JV, LLC60 participantsStarted Jan 2018

Englewood, Colorado, United States

UNKNOWN44 miles

Natural History Study in Huntington Disease Gene Expansion Carriers (HDGECs) - SHIELD HD

NCT04406636

SHIELD HD is an international, multisite, prospective, longitudinal cohort natural history study to assess the natural history of HD and its biomarkers that are associated with modulation of the number of cytosine-adenine-guanine (CAG) repeats in the mutant Huntingtin (HTT) gene. Approximately 60 patients will be enrolled into the study and followed for up to 24 months at clinical sites in North America and Europe. The results of this study will inform assessments for a future interventional treatment trial.

Huntington Disease

CHDI Foundation, Inc.70 participantsStarted May 2020

San Diego, California, United States • Englewood, Colorado, United States • Boston, Massachusetts, United States +7 more locations

COMPLETEDPhase 353 miles

A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)

NCT02544763

This trial consists of 2 parts: a double-blinded phase and an open-label extension phase. The blinded phase only will be described in this record. Participants will receive 1 of 2 doses of GWP42003-P or matching placebo. The primary clinical hypothesis is that there will be a difference between GWP42003-P and placebo in their effect on seizure frequency.

Tuberous Sclerosis ComplexSeizures

Jazz Pharmaceuticals224 participantsStarted Apr 2016

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • Los Angeles, California, United States +41 more locations

Evaluation of Topical Application of BMX-010 in Subjects With Rosacea

Natural History Study in Huntington Disease Gene Expansion Carriers (HDGECs) - SHIELD HD

A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)

Find Trials by Condition in Colorado

Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease

Leo Study Unstable Asthma

Fibromyalgia Outcome Research Trial Evaluating Synergistic Suppression of HSV-1

Comparison of VT Ablation Outcomes Using Remote MAGNETIC Navigation Versus Manual Approach in a Low LVEF Population

Dysport® Adult Upper Limb Spasticity Extension Study

Dysport® Adult Lower Limb Spasticity Study

Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1)

Dysport® Adult Upper Limb Spasticity

A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)

A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies

Once-weekly Versus Twice-weekly Carfilzomib in Combination With Dexamethasone in Adults With Relapsed and Refractory Multiple Myeloma

Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoprotein(a) (Lp(a))

Chronic Total Occlusion Percutaneous Coronary Intervention Study

Mindfulness-Based Stress Reduction, Health Education and Exercise

Long-Term Retention of Gadolinium in Bone

Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry

A Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa